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The lipidic envelope of Mycobacterium tuberculosis
promotes virulence in many ways, so we developed
a lipidomics platform for a broad survey of cell walls.
Here we report two new databases (MycoMass,
MycoMap), 30 lipid fine maps, and mass spectrom-
etry datasets that comprise a static lipidome. Fur-
ther, by rapidly regenerating lipidomic datasets
during biological processes, comparative lipidomics
provides statistically valid, organism-wide compari-
sons that broadly assess lipid changes during infec-
tion or among clinical strains of mycobacteria. Using
stringent data filters, we tracked more than 5,000
molecular features in parallel with few or no false-
positive molecular discoveries. The low error rates
allowed chemotaxonomic analyses of mycobacteria,
which describe the extent of chemical change in
each strain and identified particular strain-specific
molecules for use as biomarkers.
INTRODUCTION
Mycobacterium tuberculosis elaborates one of nature’s most
complex lipid envelopes, which forms a barrier with the human
host. This multilayered cell wall contains an inner phospholipid
bilayer and an outer layer of a-alkyl, b-hydroxy mycolic acids
and other long-chain lipids (Daffe´ and Draper, 1998; Hoffmann
et al., 2008; Zuber et al., 2008). During a decades-long infection
cycle, this unusually thick and hydrophobic barrier controls
import of essential host metabolites and passage of antituber-
cular drugs (Adams et al., 2011), and it releases lipid antigens
and adjuvants into the host (Geisel et al., 2005). During infection
(Kondo et al., 1970), nutrient deprivation (Rustad et al., 2008;
Singh et al., 2009), and genetic regulation (Raman et al., 2006),
mycobacteria respond by broadly reorganizing their cell walls,Chemistry & Biology 18, 1537–154providing a need for systems biology approaches to globally
measure bacterial responses. This goal has been achieved for
transcripts (Homolka et al., 2010; Rohde et al., 2007; Schnap-
pinger et al., 2003) and proteins (Kruh et al., 2010) and has
been partially achieved for the cytosolic metabolites that do
not form membranes (de Carvalho et al., 2010; Marrero et al.,
2010).
For lipids, sensitive mass spectrometry and nuclear magnetic
resonance profiling methods are emerging that nearly simulta-
neously detect many types of lipids. These methods sensitively
detect several previously identified lipid families whose mass/
charge ratios (m/z) (Jain et al., 2007; Matsunaga et al., 2004;
Sartain et al., 2011) or nuclear magnetic resonance (NMR)
signals (Mahrous et al., 2008) match predefined values. An ideal
lipidomics system would offer both broad coverage of many
thousands of molecules in mycobacterial lipidomes as well as
the ability to convert any unnamed compounds of known mass
to named compounds through accurate mass retention time
(AMRT) databases or collisional mass spectrometry. In addition,
bioinformatics methods for organizing and comparing all lipids
among two bacteria or two bacterial states are needed. Myco-
bacterial lipids, especially large uncharged lipids associated
with the mycolate layer, differ from well-studied anionic phos-
pholipids of model organisms with regard to mass and their ioni-
zation properties in mass spectrometry. Therefore, approaching
this goal required development of new mycobacteria-specific
mass spectral databases and software protocols for automated
ion finding, as well as broadly separating chromatography opti-
mized for unusually hydrophobic lipids associated with the my-
colate membrane.
Here we report two new mycobacterial databases (Myco-
Mass, MycoMap), an integrated set of software methods, and
a universal separation method, which, when coupled with
collisional mass spectrometry, meet most of these goals.
Using an extract of lipids from one bacterial strain taken at one
point in time, these methods provide a snapshot profile of
more than 5,000 molecular features, which approach the goal
of solving one static lipidome. Further, comparative lipidomics9, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1537
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Mycobacterial Lipidomicsseeks to measure lipid changes in an organism-wide basis as
biological events unfold over time or to broadly characterize
the molecules that differ between any two bacteria (chemotax-
onomy). These kinds of applications require that many lipi-
domes be generated in a short period of time and bio-
finformatic methods for aligning mass spectrometry signals
across multiple datasets to identify the subset of changed
molecules. Taking advantage of stringent data filters that
generated a low false-positive rate, this comparative lipidomics
platform could reliably detect thousands of molecular changes
after infection or among mycobacterial strains, enabling
chemotaxonomic analyses of experimental and clinical strains
of mycobacteria.
RESULTS
The MycoMass Database
To compile the expected m/z from known mycobacterial lipids,
we first created an inventory of literature reports relating to
M. tuberculosis and other medically important mycobacteria.
Lipids were organized according to LIPID MAPS criteria, using
a four-level classification divided into seven categories and
23 classes based on generic structures, from which 43 sub-
classes and 58 families were defined based on differences in
the number or nature of carbohydrate or lipid moieties (Fig-
ure 1) (Fahy et al., 2005). Each lipid family contained an
average of 95 alkylforms, which are individual molecules
differing in the length and saturation of fatty acyl or polyketide
backbones. The resulting MycoMass database catalogs more
than 5,000 neutral species (M) and their deduced negative
and positive ions, for a total of 32,438 entries (Figure S1 avail-
able online).
Like the independent effort of Sartain et al. (2011), MycoMass
represented the first step toward a mycobacterial lipidome,
because it organized and defined the scope of known lipid
families requiring detection. Second, MycoMass also served
as the input data that allow for mass comparison with detected
molecules to support development of new automated ion
annotation protocols. Third, because more than 40 of the 58
cataloged lipid families are lacking in eukaryotic cells or
Gram-negative bacteria, MycoMass provides a quantitative
summary of the divergence of the mycobacterial lipidome
from widely studied model organisms. MycoMass lists mycoke-
tides, phthiocerols, menaquinones, mycolactones, and hy-
droxyphthioceranic, mycolipanolic, phthienoic, mycolipodienic,
mycosanoic, mycocerosic, and mycolic acids, as well as many
other lipids found mainly or exclusively in mycobacteria and
closely related actinobacteria. Therefore, MycoMass contains
specific mass targets that could serve as biomarkers of in-
fected cells. Many neutral lipids are distinct in mass and struc-
ture from anionic phospholipids that dominate in Gram-nega-
tive bacteria or eukaryotic cells. The divergence of MycoMass
entries from databases for model organisms illustrate why the
latter, despite their high quality, do not support studies of
mycobacterial pathogenesis (Dennis et al., 2010; Quehenberger
et al., 2010; van Meer et al., 2007). Also, the unusual hydropho-
bicity and high mass of mycobacterial neutral lipids necessi-
tated the development of new methods of chromatography
and ionization protocols.1538 Chemistry & Biology 18, 1537–1549, December 23, 2011 ª2011Chromatographic Design
We harvested mycobacteria from plates, broth, or infected mice
and extracted lipids with chloroform and methanol. Although
more complex than simultaneous (i.e., shotgun) ionization,
chromatographic separation of lipids in a mixture prior to ioniza-
tion offers advantages. Column retention predicts polarity of
unknown molecules, facilitating their identification. Chromatog-
raphy separates molecules of similar mass in time, creating
a large two-dimensional AMRT area to resolve individual compo-
nents within mixtures containing thousands of ions. Perhaps the
key advantage of chromatography is reducing the chemical
dissimilarity of molecules entering the electrospray source at
any moment. Dissimilar molecules can dramatically alter the
efficiency of electrospray ionization, leading to cross-suppres-
sion, a phenomenon that particularly affects apolar lipids that
dominate mycobacteria (Taylor, 2005).
Our first generation method used acetone precipitation to
separate lipids into batches, followed by several reversed-phase
high-performance liquid chromatography (HPLC) methods to
optimize separation (Figure S2A). Multiple datasets were then
reconciled into one lipidome. As expected, phospholipids and
mycolyl glycolipids precipitated (Borgstrom, 1952; Takayama
and Armstrong, 1976), but triglycerides, phthiocerol dimyco-
cerosates (PDIMs), and many other lipids partitioned into both
phases (Figure S2B). Any biological variable modifying the abun-
dance of individual molecules in the mixture can change the
partition coefficient of other lipids. Therefore, fluid-phase sepa-
rations, despite their wide use for targeted analyses, are unsuit-
able for lipidomics. This development effort highlights a general
difference between lipidomic and typical analytical lipid chem-
istry problems: rather than optimizing for any single lipid, all
new methods must be validated for extremely diverse lipids in
one sample.
To avoid partitioning and errors in reconciling many datasets,
our second generation replaced five HPLC systems with one
single-step method for the analysis of total lipid extracts (Fig-
ure 2A, black). The key challenge was to devise a normal-phase
chromatography that solubilizes, separates, and allows ioniza-
tion of highly diverse molecules using one general method.
We evaluated each method change on the whole dataset of
unnamed molecules (Figure 2B) and four named benchmark
lipids of low, intermediate, and high polarity spanning a wide
range of signal intensity (102–107 counts). These benchmark
lipids were PDIM, trehalose monomycolate, diacylated sulfo-
glycolipids, and cardiolipin, representing apolar lipids, glyco-
lipids, sulfolipids, and phospholipids, respectively (Figure 3A).
By tracking these, we successfully developed a hexanes/
isopropanol/methanol solvent system for normal-phase chroma-
tography that separates families with even density and allowed
sensitive detection over a wide dynamic range (Figure 2B). This
simplified system reduced lipidome generation time from several
days to 45min, allowing generation of 30 lipidomes in 1 day. This
advance fulfilled a crucial performance goal for comparative lip-
idomics, which requires serial generation of lipidomes in tripli-
cate under rigorously comparable conditions.
Optimizing Lipidomic Detection
Whereas metabolomics conventionally focuses on aqeous cyto-
solic intermediates that generate energy (de Carvalho et al.,Elsevier Ltd All rights reserved
Figure 1. MycoMass Database Content
List of the lipids cataloged in theMycoMass database (Figure S1). This database follows the LIPIDMAPS organizational tree and uses lipid families’ names found
in the mycobacterial literature in level 4. Phosphatidylinositol mannosides (PIMx) contain 1–6 mannosyl residues (x) and sulfoglycolipids (AcxSGL) contain 2–4
fatty acyl chains (x). Alkylforms vary by the saturation and carbon length of acyl chains and/or by the length of carbon backbones.
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specialty of lipidomics provides detailed information about
hydrophobic molecules that form membrane barriers. We in-
vented a lipidomics system to investigate how themycobacterial
cell wall, acting as the interface between the host and pathogen,Chemistry & Biology 18, 1537–154regulates transport of drugs, antigens, and metabolites from the
phagosome into the bacterium. Cytosol profiling typically uses
ethyl acetate to extract aqueous-soluble compounds, empha-
sizing somewhat polar molecules of lower mass (50–300 atomic
mass units) and rapid turnover (seconds). Lipidomic methods9, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1539
Figure 2. Lipidomics Platform
(A) Lipid extracts (dark blue) enter a workflow involving a universal normal-phase HPLC-MS system (black), software-assisted raw data extraction (green),
computational comparative analysis (red), database and dataset annotation (purple), and molecular discovery through collisional mass spectrometry (light blue).
This second-generation system for comparative profiling emphasizes a single-step chromatography system, in contrast to a first-generation method that uses
fluid phase separation and multiple HPLC systems (Figure S2).
(B) Extracted ion chromatograms of the overall features detected with high, intermediate, and low intensity by analyzing M. tuberculosis H37Rv total lipids.
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Mycobacterial Lipidomicsextract higher-mass (300–3,000 atomic mass units), low-turn-
over (days) compounds into chloroform-containing solvents,
which, for mycobacteria, are unusually diverse long-chain lipids.
Comparative lipidomics requires precise normalization of
input lipids as well as reproducible and sensitive detection of
aligned, replicate lipidomes. After initially adopting published
ionization conditions for anionic membrane phospholipids
(Kruve et al., 2010), reduction of countercurrent gas flow and
increasing voltage produced greater than 100-fold increases in
sensitivity and revealed high mass neutral lipids that were other-
wise undetectable, such as trehalosemonomycolate (Figures 3B
and 3C). These gains resulted from generating greater force
toward the detector and were seen for many ions in the myco-
bacterial lipidome. This dramatic and broad-based improvement
in sensitivity resulted from adjustments of ionization conditions
that are better suited to the larger, uncharged lipids that populate
the mycolate layer.
Interlipidome comparisons rely on precise normalization of
input lipids, which was accomplished using cultures harvested
at a similar optical density of 0.6 (±0.1) and weights determined1540 Chemistry & Biology 18, 1537–1549, December 23, 2011 ª2011with less than 1% SD. Using this method, the SD of triplicate
intensity measurements of benchmarks was about 2% for tech-
nical replicates and 10% for biological replicates (Figure 3D).
Thus, experimental error was low in absolute terms and derived
mainly from non-uniform bacterial culture rather than LC-MS
detection. Normalization at the detection level was further
confirmed by continuous detection of calibrants, tracking total
ion current generated by all lipids, and by monitoring abundant
structural lipids that serve as housekeeping controls. For ex-
ample, cardiolipin showed highly reproducible intensity among
biological replicates (Figure 3D) and did not change significantly
between diverse samples subject to biological variables (data
not shown). Serial dilution of input lipids determined that
500 mg/ml provided nonsaturating and near linear detection of
benchmarks (Figure 3E) and other lipids over a 10-fold or higher
change in concentration. Thus, a 20 ml injection from scant in vivo
specimens yet produced allowed sensitive and broad lipidomic
coverage with benchmark lipids detected below the picogram
range (Figure S3). Therefore, the platform met the criteria for
sensitivity, reproducibility, and relative quantitation.Elsevier Ltd All rights reserved
Figure 3. Validation of a Universal Normal-Phase HPLC-MS Detection
(A–C) Structures (A) of diverse benchmark lipids for HPLC-MS method optimization related to countercurrent gas (B) and source voltage (C) as measured in
biological replicates (D).
(E) Relationship of signal intensity derived from areas under the curves of ion chromatograms to input mass of total lipid. Data are representative of three or more
experiments.
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This single-step universal chromatography method was imple-
mented for assigning the retention time (RT) of each lipid family
as an organizing principle for mapping of the lipidome. Large
raw datasets were processed by XCMS for noise filtering, peak
picking, and deconvolution to resolve coeluting ions and peak
alignment across replicates so that features with equivalent
AMRT values are aligned across biological conditions and theirChemistry & Biology 18, 1537–154intensities reported in a final data matrix (Smith et al., 2006) (Fig-
ure 2A, green). A feature was defined as a three-dimensional
value ofm/z, RT, and intensity detected in triplicate. Typical anal-
yses of M. tuberculosis lipid extract yielded a data matrix of
6,000 and 5,000 features acquired in the positive and nega-
tive ionmode, respectively (Figure S4). Evenwhen lacking chem-
ical names, features with high fold change have value asmarkers
of the bacterial response (Figure 2A). Nevertheless, we sought to9, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1541
Figure 4. Mapping the Lipidome of M. tuberculosis H37Rv
(A) HPLC-MS dataset ofM. tuberculosisH37Rv of6,000 features, which are three-dimensional coordinates of linkedm/z, RT, and intensity. One lead compound
in each cluster was tentatively identified by automated annotation using MycoMass, confirmed by four analytical criteria, and mapped to the chromatographic
system in positive (B) and negative (C) ion mode.
(B and C) Extracted ion chromatograms of mapped lipid families. Neutral formulas of the studied alkylforms and detected m/z of the respective [M+NH4]
+ or
[M+H]+ adducts (B) and [M–H] forms (C) are indicated. RTs of lipids typically varied by less than 5 s in one experiment, but varied up to 60 s among users with
differing columns. Phosphatidylinositol mannosides (PIMx) are listed according to the number (x) of mannosyl residues. Thirty lipid families mapped in this way
comprise the MycoMap. Features annotation and collisional MS are shown in Figure S4.
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named compounds to allow broad monitoring of known
molecules.
We created fine maps of 30 families of lipids by repeatedly
applying a four-step process (Figure 4A). First, when plotted as
RT versus m/z, features self-organize into clusters comprising
many alkylforms with the same head group. This clustering
results from normal-phase chromatography, which resolves all
molecules into separate families, but not alkylforms within
a family. Tight clustering facilitates identification of families and
limits their overlap in RT, reducing molecular heterogeneity and
cross-suppression between disparate lipid families. Second,
clustered features were tentatively assigned to a known lipid
using an in-house designed script using R software (see Supple-1542 Chemistry & Biology 18, 1537–1549, December 23, 2011 ª2011mental Information), allowing automatic naming of features
whose m/z matched within 10 ppm to any entry in MycoMass.
This software achieved tentative annotation of 624 and 366
features in positive and negative ionmode datasets, respectively
(Figure S4).
Step 3 tests the assignments by comparing alkylform diver-
sity, RT, and collisionalMS of feature groups to knownmolecules
(Figure S4). For example, features initially annotated as PDIM by
software were found to match the RT of a synthetic PDIM stan-
dard (3.6 min, data not shown) and appeared as an alkane series
of the expected length (C87-C102) of M. tuberculosis PDIMs
(Figure S4; Figure 5A). One ion of m/z 1371.413 matching the
expected m/z for the ammoniated adduct of C91H180O5 PDIM
(m/z 1371.412) showed the fragments expected of phthiocerolElsevier Ltd All rights reserved
Figure 5. In Vitro and In Vivo Fine Mapping of M. tuberculosis H37Rv Lipid Families
(A–C) Extracts of M. tuberculosis H37 Rv grown in vitro were subject to detection of PDIM, trehalose monomycolate (A and B), and 28 other lipids (Figure S5)
illustrating the PDIM detected alkylforms (A) and RT profiles (B) that match by color and were confirmed by collisional mass spectrometry (C).
(D)M. tuberculosis Erdman 2.5 grown in brothmedia or in one infectedmousewere similarly analyzed for the PDIMA/A0 andB alkylformswith the indicated overall
carbon number. Similar results were found in separate analysis of three mice (Figure S6).
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Mycobacterial Lipidomicsand mycocerosyl substructures (Figure 5C). We repeated this
process for 30 annotated lipid families (Figures 4B and 4C;
Figure S4). Because most of the mycobacterial lipidome’s diver-
sity is found in neutral lipids (Figure S1), we obtained larger
datasets in the positive ion mode than in the negative ion
mode (Figures 4B and 4C). This result contrasts with conven-
tional lipidomic studies that emphasize detection of negatively
charged membrane phospholipids of mammalian cells. Both
modes provided a high dynamic range that spanned four
log orders of magnitude, so diacylglycerides, monoacyl PIM,
and other strongly detected lipids (106 counts), as well as
PDIM, triglycerides, menaquinone, sulfoglycolipids, mannosyl
phosphomycoketide, lysophospholipids, and lower-intensity
PIM families (104 counts), could be tracked in parallel with
one injection.Chemistry & Biology 18, 1537–154Fine Mapping
Finemapping is a processwhereby each alkylformwithin a family
is separately assigned. For example, PDIM naturally occurs with
between 87 and 102 total carbon atoms within A and B families,
distinguished by methoxy or keto substitutions (Constant et al.,
2002) (Figure 5A). Sixteen length variants in two families predict
32 alkylforms. We detected and mapped all 32 alkylforms as
nearly overlapping chromatograms (Figures 5A and 5B). Simi-
larly, we mapped 28 trehalose mycolates (Figure 5B) and the
alkylforms of 28 other lipid families, covering 318 compounds
to create MycoMap (Figure S5). Fine mapping supports applica-
tions that take advantage of species- or strain-specific patterns
in actinobacteria for clinical diagnosis or chemotaxonomic as-
signment (Song et al., 2009). Furthermore, alkylforms within
a family can change differentially in response to a biological9, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1543
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example, M. tuberculosis harvested from mouse lung produces
longer PDIM alkylforms compared to bacteria from in vitro
culture, resulting from increased methylmalonate availability in
tissues (Jain et al., 2007). We detected 32 alkylforms of PDIM
produced in infected mouse lungs, which confirmed previously
reported in vivo lengthening (Figure 5D; Figure S6). Thus, fine
mapping illustrates that the broadly comparative method
described here can meet requirements previously accomplished
with targeted ion finding. Detection is adequately sensitive for
lipids extracted from infected tissues, where mammalian lipids
greatly predominate.
Comparative Lipidomics
Comparative lipidomics requires efficient algorithms to process
raw LC-MS data, measure the intensity of individual chromato-
grams, and align thousands of features across many lipidomes
to generate a data matrix. Our first-generation (Figure S2) and
other (Sartain et al., 2011) data extraction methods pool isotopes
and adducts of deduced neutral molecules (M) as one intensity
value. This approach causes quantitative errors related to
adduct assignment and pooling of many intensity values, which
leads to quantitative errors when count values detected in the
nonlinear range of counts to mass are summed. When
comparing two large datasets, these kinds of errors caused
many ions to be incorrectly assessed as changed molecules,
leading to unacceptably high false-positive molecular finding
rates. Manual inspection of chromatograms improved reliability
but were too cumbersome to evaluate more than 100,000 peaks
in one experiment. Therefore, we implemented XCMS ion finding
algorithm, which treats all ions as separate features and
bypasses ion batching errors. Implementation of reliable auto-
mated ion finding algorithms was the key advance allowing
comparison of datasets with more than 100,000 features.
Next, Mass Profiler Professional software was implemented
for comparisons and statistical analysis of XCMS-generated
data matrices to report changed features and their p values cor-
rected with the Benjamini-Hochberg multiple comparisons test
(Figure 2A, red). To quickly highlight significant changes, results
were displayed in two-dimensional scatter plots of fold change
versus corrected p value, also known as volcano plots (Figures
6A–6D). Because a typical comparative lipidomics experiment
generates hundreds of changed molecules, which collectively
exceed any capacity for detailed biological validation, the over-
riding design objective is limiting false-positive molecular dis-
covery. Therefore, we used stringent filters to remove ions
absent in any replicate and those with intensity values showing
high variance (corrected p > 0.05). We considered a feature to
be changed when its intensity value changed at least two-fold
(Figures 6C and 6D, red dots), which exceeds the sum of the
typical variation observed among biological triplicates (Fig-
ure 3D). Despite these stringent filters, the biofinformatic pipeline
permitted broad coverage, typically 4,000 to 10,000 compari-
sons per experiment. By comparing two triplicate analyses of
the same bacterial culture, the percentage of features that are
described as changed represented the false-positive molecular
discovery rate (Figure 6A). Remarkably, 6,498 pairwise compar-
isons yielded no false-positive results from cumulative errors in
extraction, separation, detection, and software analysis. Similar1544 Chemistry & Biology 18, 1537–1549, December 23, 2011 ª2011analysis for biological replicate cultures showed an error rate of
0.7% (Figure 6B). Thus, errors derive mainly from culture rather
than LC-MS detection. The near zero rate of false molecular
detection provided a blank canvas against which any molecules
changing after introducing biological variables would likely be
caused by the biological variable, setting the stage for chemo-
taxonomy analyses of mycobacteria.
Chemotaxonomy
The goals of chemotaxonomy are two-fold: (1) measure the
number of changed molecules as a descriptor of chemical
relatedness of two bacteria and (2) provide a list of changed
molecules to discover biomarkers. We compared virulent
M. tuberculosis H37Rv with avirulent M. smegmatis, and with
a reference strain of the W Beijing clade of M. tuberculosis
(HN878) (Figures 6C and 6D). Molecular features showing inten-
sity changes that met variance criteria for genuine differences
showed two patterns. For any feature that shows background
signal in one dataset, its intensity is assigned as 1 rather
than 0. Therefore, all or nothing changes in molecules, which
represent the best biomarkers, appear as high (>210) but not
infinite change values. Features with a 2- to 210-fold change rep-
resented features present in both bacteria with altered concen-
trations. These features might represent regulated lipids that
define the physiological state of the bacterium. The intraspecies
and intragenus comparisons detected 648 changes (11%) and
4,339 changes (47%), respectively (Figures 6C and 6D). Thus,
the scope of chemical change correlates with genetic related-
ness, validating the discriminatory potential of this lipidomics
method.
Because each feature contains embedded AMRT information
and can be subjected to automated annotation, this com-
parison can rapidly identify strain specific biomarkers without
further experimentation. For example, the W Beijing lineage of
M. tuberculosis is hypervirulent in mice (Dormans et al., 2004;
Manca et al., 2005; Reed et al., 2004) and has emerged world-
wide as a human pathogen with distinct transmission features
(Glynn et al., 2002). Among 5,886 pairwise comparisons between
M. tuberculosisH37Rv and the clinical reference strain for Beijing
(HN878), we identified 303 features upregulated in the Beijing
strain, of which 69 represented all or nothing changes (Figure 6C,
enlarged). Automated and manual annotation showed that 38
are alternative adducts and isotopes of the same alkane series
with nominal neutral mass values (M) between 1785 and 1911
(Figure 6C, green; Figure S7A). These ions and their key frag-
ments (Figure 6E) correspond to the expectedmassof triglycosy-
lated phenolic glycolipids (PGLs). This virulence-associated
glycolipid has been previously identified on a genetic basis by
intact polyketide synthase 15/1 in the W Beijing lineage, but not
H37Rv, which has a frameshift in this locus (Constant et al.,
2002). Thus, we identified a known strain-specificmolecule using
a rapid and unbiased cell wall screen. Identification of PGLs in
38 distinct molecular forms represents a redundant and
convincing form of detection that is not possible using bio-
informatic methods that batch isotopes and adducts.
Lipidomic versus Targeted Scanning for PGLs
The relationship between Beijing lineage and PGLs was previ-
ously known, but there were no clinical tests for the screeningElsevier Ltd All rights reserved
Figure 6. Comparative Chemotaxonomy
(A–D) Pairwise comparison of extractable lipids represented as volcano plots, showing in red the features meeting criteria for two-fold change and significance
(p < 0.05, corrected for multiple comparison) also indicated as a percentage of all features (n). M. tuberculosis H37Rv lipid extract from one (A) or two (B) liquid
cultures were analyzed in triplicate and compared withM. tuberculosis Beijing HN878 (C) orM. smegmatis (D). Among features uniquely present in the W Beijing
strain (C, inset, and listed Figure S7A), 38 (green) corresponded to isotopes (M, M+1, M+2) and adducts (NH4
+ or Na+) of a triglycosylated PGL alkane series, as
illustrated for two alkylforms of nominal masses of 1827 and 1841.
(E) Collisional mass spectrometry of [M+NH4]
+ adduct of PGLs confirmed structure composed of a phthiocerol core esterified by C27 and C30mycocerosic acids
(R1COOH, R2COOH).
(F and G) Extracted ion chromatograms of a representative alkylform of the monoglycosylated (m/z 1553.442) or triglycosylated (m/z 1845.554) form of PGLs for
laboratory and patient isolates show sensitive detection that is not confounded by other lipids and separate detection of the two PGL glycoforms. The mass
spectrum of triglycosylated PGLs is shown in Figure S7B.
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Mycobacterial Lipidomicsof triglycosylated PGLs found in virulent strains, or for comparing
this virulence-associated molecule with the monoglycosylated
form found in Bacillus Calmette-Gue´rin (BCG) (Daffe´ andChemistry & Biology 18, 1537–154Laneelle, 1988). Genetic tests of the pks15/1 locus generally
rule out PGL production when abnormal, but are not sufficient
to rule in PGL production, because many other genes are9, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1545
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Mycobacterial Lipidomicsneeded (Malaga et al., 2008; Pe´rez et al., 2004). Because the
best available chemical test, radio-thin layer chromatography,
requires biosynthetic labeling in biosafety level 3, it is not feasible
in clinical laboratories (Reed et al., 2004). Therefore, despite
considerable interest in the dispersion of Beijing strains world-
wide and direct evidence for PGLs as a virulence factor in
mice, studies of PGLs in human isolates have been limited. Using
AMRT (RT = 4min,m/z 1845.547) and a diagnostic finemap from
the lipidomics platform (Figure 6C), we converted from a broad
scanning mode to a simplified, specific analysis of ions corre-
sponding to monoglycosylated (m/z 1553.442) and triglycosy-
lated (m/z 1845.554) PGLs. Signal intensity is more than
100-fold above baseline levels and is not confounded by any
other ion (Figure 6F; Figure S7B). We applied this test to detect
PGLs in patient isolates from South Korea (Figure 6G) and
identified both mono- and triglycosylated PGLs in isolates geno-
typed as Beijing strains with an intact pks15/1 locus. Further, we
identified an isolate with discordant production of themono- and
triglycosylated PGLs. These studies illustrate the transition from
lipidomic scanning to a focused analysis. In contrast with the
current gold standard test requiring radioactive labeling, this
test uses standard media and is rapid, sensitive, and chemically
specific, because collision-induced dissociation (CID)-MS pro-
vides chemical detail. More generally, all 303 events that meet
statistical and fold change criteria become candidate targets
for strain-specific biomarkers or determinants of W Beijing
physiology.
DISCUSSION
Based on its sensitivity, this comparative lipidomics system can
be used to evaluate any genetic or biological perturbation, even
within infected cells. Based on the low rate of false-positive
molecular discovery, it is possible to embark on unbiased dis-
covery for all molecules regulated by any single gene deletion
or metabolic perturbation. Therefore, this method is currently
being applied to determine cell wall changes induced by antitu-
bercular drugs, evolution of multidrug resistance, dormancy,
cellular infection, and iron deprivation. The development of
a new clinically useful test for the PGL virulence determinant
provides a glimpse of the high value of extending general lipi-
domic maps of model organisms to pathogens with unusual
lipid repertories. A simple test to monitor PGLs in clinical
M. tuberculosis strains allows new investigation to determine
whether the virulence-inducing effects seen in mice might occur
in humans or are outweighed by fitness costs or decreased
transmission from altered immune response (Comas et al.,
2010).
These studies also provide a quantitative estimate of the
scope of current knowledge of the mycobacterial lipidome.
Even using MycoMass, the largest mycobacterial database
available, we annotate only up to 20% of the detectedmolecules
in any lipidome. The events corresponding to unnamed mole-
cules might derive from fragmentation or redundant detection
of unexpected adducts or might simply be molecules produced
byM. tuberculosis that are not known in the literature. Based on
the low rates of source fragmentation and redundant detection of
molecules in altered ionization states observed during the map-
ping process, it appears that knowledge of the mycobacterial1546 Chemistry & Biology 18, 1537–1549, December 23, 2011 ª2011lipidome is far from complete. Indeed, the mycobacterial
genome has an unusually large number of lipid synthases, and
for many of these, their products remain unknown. These facts
are surprising given the worldwide scope of the tuberculosis
epidemic, with an estimated 1.6 million deaths per year (World
Health Organization, 2009). Subtraction of all entries comprising
MycoMass from those in any routinely generated lipidome
shown here provides a tangible list of unnamed molecules that
represents a map for solving the molecular toolkit of the world’s
most devastating bacterial pathogen.
SIGNIFICANCE
Mycobacterium tuberculosis remains one of the world’s
most deadly bacterial pathogens and survives within human
cells using a protective lipid envelope comprised of distinct
layers. This lipidic cell wall regulates uptake of nutrients and
antitubercular drugs while shedding lipid adjuvants, anti-
gens, and pathogen-specific markers of infection. To profile
mycobacteria on an organism-wide basis, we first solved a
static M. tuberculosis lipidomic dataset comprised of mass
spectrometry datasets, a lipid database containing more
than 5,000 neutral masses from medically relevant myco-
bacteria, and an accurate mass-retention time map of
more than 300 lipidswith 30 finemaps of alkyl chain variants.
Among 58 lipid types in the MycoMass and MycoMap data-
bases, more than 40 are lacking in eukaryotic or Gram-nega-
tive organisms, illustrating the need to move beyond model
organisms for direct study of the specialized molecules in
pathogens. We implemented a broadly separating, single-
step chromatography system together with automated ion
finding and statistical and annotation software to create a
platform for comparative lipidomics. This platform itera-
tively solves replicate lipidomes before and after infection
or among various clinical isolates to provide broadmeasure-
ments of pathogen response and chemotaxonomic infor-
mation. Pairwise comparison of 6,000 aligned features
describes chemical relatedness of mycobacteria with low
false-positive molecular discovery rates. Broad chemotaxo-
nomic analyses of mycobacteria measured the extent of
chemical change associated with species and strain-
specific variants and provided detailed lists of themolecules
changed. Unbiased scanning of a W Beijing strain of
M. tuberculosis identified the known biomarker phenolic
glycolipid and provided the basis for a new clinically appli-
cable test for forms of this glycolipid that have or have not
been associated with virulence.
EXPERIMENTAL PROCEDURES
MycoMass Database
Lipids forM. tuberculosis,M. smegmatis,M. bovis BCG, M. avium,M. leprae,
and M. marinum were reported according to LIPID MAPS conventions. Alkyl-
forms are variations in length and unsaturation of lipids based on all possible
lipid substitutions, except for PIMs and trehalose dimycolates in which
a smaller number of specific combinations are known to occur (Fujita et al.,
2005; Gilleron et al., 2006). From calculated neutral mass values (M), the
expected [M+H]+, [M+NH4]
+, [M+Na]+, [M–H], [M+HCOO], and
[M+CH3COO]
 are shown to five significant figures. Due to their distinctive
appearance in MS, [M+Fe54/56–2H]+ mycobactins and phosphatidyl ethanolo-
mine [2M+H]+ were listed for a total of 32,438 entries to the MycoMassElsevier Ltd All rights reserved
Chemistry & Biology
Mycobacterial Lipidomicsdatabase (Figure S1) (http://www.brighamandwomens.org/research/depts/
medicine/rheumatology/labs/moody).
Mycobacterial Culture
M. smegmatis mc2155, M. bovis BCG, and M. tuberculosis H37Rv (Trudeau
Institute) and M. tuberculosis HN878 (Robert N. Husson) were cultured in
6 ml Middlebrook 7H9 broth supplemented with 10% oleic acid/albumin/
dextrose/catalase (Becton Dickinson) in 50 ml polystyrene tubes (Corning)
and shaken at 100 rpm at 37C until visible growth appeared, up to 2 weeks
depending on the species. OnemL of the starter culture was transferred in trip-
licate to 45 ml fresh media in 250 ml sterile polystyrene containers with vented
caps and in singlicate to 45 ml of fresh media supplemented by 0.05% Tween
80 for growth monitoring by OD600 measurement. Triplicate Tween-free
cultures were harvested when the Tween culture reached 0.6 (±0.1) OD600.
W Beijing family clinical isolates were obtained from retreatment (subjects
#126 and #138) and one newly diagnosed case (subject #57) was obtained
from a TB natural history study (ClinicalTrials.gov identifier: NCT00341601)
at the National Masan Tuberculosis Hospital in the Republic of Korea. Cultures
were obtained following sputum processing, microscopic examination for
acid-fast bacilli and the BacT liquid culture system (Biomerieux) or from
Ogawa slants (ShinYang Chemicals, Korea) incubated at 37C in ambient air
for a maximum of 8 weeks. Primary cultures were identified using classical
methods (Le´vy-Fre´bault and Portaels, 1992) and stored at 80C. Drug
susceptibility testing was performed by the proportion method on Lowenstein-
Jensen medium using previously described methods (Canetti et al., 1969;
Wayne, 1974). For mass spectrometry, isolates were cultured in 20 ml of 7H9
medium supplemented with 10% albumin/dextrose/catalase (EMD Chemicals,
San Diego, CA) containing glycine-alanine salts and incubated in 250ml bottles
in a rolling incubator at 37C.
Lipid Extraction
LC-MS grade solvents (Fisher) and clean borosilicate glassware (Fisher),
amber vials (Supelco), and Teflon-lined caps (Fisher) were used. Laboratory
strains were centrifuged (4,000 rpm,10 min) to clarify culture supernatants,
which were passed twice through a 0.22 mm filter to detect secreted
compounds. Cell pellets were washed twice in 10 ml Optima water, resus-
pended in 1 ml of CH3OH, transferred to a 50 ml amber glass bottle, and con-
tacted with 25 ml CHCl3/CH3OH (2:1, v/v) overnight to sterilize bacteria.
CHCl3/CH3OH suspensions were transferred in 50 ml conical glass tubes
and shaken on an Orbitron rotator for at least 1 hr. After centrifugation, lipid
extracts were decanted, and bacteria pellets were subjected to two additional
extractions using CHCl3:CH3OH (1:1, v/v) and CHCl3:CH3OH (1:2, v/v) with
pooling of extracts and evaporation with GeneVac EZ-2 (SP Scientific) using
the low boiling point mixture setting. Dried lipids were resuspended in
a minimum volume of CHCl3:CH3OH (1:1, v/v) and dried under nitrogen in pre-
weighed vials, then reweighed in triplicate on microbalance (Mettler Toledo,
XP205), and values were reported when fully dried as shown by replicate
measurements showing less than 1% variance. Using 2 mg of lipid ex-
tract, replicate measures showed variance of 20 mg, providing mass errors
below 1% for in vitro-derived samples. Extracts were then redissolved in
CHCl3:CH3OH (1:1, v/v) at 1 mg/mL. For clinical isolates, mid-log phase
cultures (OD = 0.5±1) were centrifuged at 3,000 rpm for 15 min and extracted
as described (Reed et al., 2004).
HPLC-Electrospray Ionization Quadrupole Time-of-Flight Mass
Spectrometry
Using an Agilent Technologies 6520 Accurate-Mass Q-Tof and a 1200 series
HPLC system with a Varian Monochrom diol column (3 mm 3 150 mm 3
2 mm) and a Varian Monochrom diol guard column (3 mm 3 4.6 mm), up to
50 mg of lipid extract was dried under nitrogen and resuspended at
0.5 mg/mL in solvent A (hexanes:isopropanol, 70:30 [v: v], 0.02% [m/v] formic
acid, 0.01% [m/v] ammonium hydroxide), filtered or centrifuged at 1,500 rpm
for 5 min to remove trace nonlipidic materials prior to transfer to a glass
autosampler vial (Agilent). Ten mg were injected, and the column (20 C) was
eluted at 0.15 ml/min with a binary gradient from 0% to 100% solvent B
(isopropanol:methanol, 70:30 [v/v], 0.02% [m/v] formic acid, 0.01% [m/v]
ammonium hydroxide): 0–10 min, 0% B; 17–22 min, 50% B; 30–35 min,
100% B; 40–44 min, 0% B, followed by additional 6 min 0% B postrun.Chemistry & Biology 18, 1537–154Ionization was maintained at 325C with a 5 l/min drying gas flow, a 30 psig
nebulizer pressure, and 5,500 V. Spectra were collected in positive and nega-
tive ion mode from m/z 100 to 3,000 at 1 spectrum/s. Continuous infusion
calibrants included m/z 121.050873 and 922.009798 in positive ion mode
and m/z 112.985587 and 1033.98810 in negative ion mode. CID-MS was per-
formed with an energy of 30–60 V. For any large-scale comparative analysis,
the column is conditioned by three succesive 10 min elutions with B, B/A 1:1
(v/v) and A solvents followed by three mock injections with solvent cycling
before mycobacterial samples are analyzed.
HPLC-MS Data Extraction and Alignment
Raw data files were converted to mzData using MassHunter and processed in
R using the XCMS (version 1.24) (Smith et al., 2006) centWave peak finder
method designed for high mass accuracy data (Tautenhahn et al., 2008).
XCMS was downloaded from http://metlin.scripps.edu/xcms/index.php.
Briefly, peaks were deconvoluted and aligned across samples using an s/n
threshold of 5, a maximum tolerated m/z deviation of 10 ppm, a frame width
ofmzdiff = 0.001, a peak width of 20–120 s, and a band width of 5. The aligned
output consisted of accurate mass, retention time (RT = 1–2,640 s), and inten-
sity of each peak and was exported as .csv files for analysis in Mass Profiler
Professional or for automatic annotation in R. Although mass accuracy of
<2 ppm was achieved with optimized conditions, trace compounds from bio-
logical sources can provide lower mass accuracy, leading to a 10 ppm mass
window, which was validated to efficiently capture data points that describe
a chromatographic peak when detected in complex mixtures with varying
peak intensity.
Semi-automated Annotation
Features, medianm/z, andmedian RT information from XCMS output were ex-
ported and compared to the MycoMass database formatted as .csv files and
performed in R (version 2.11.1) using an in-house designed script. Initial
matches for a reference database yielded 1,020 and 768matches for the posi-
tive and negative ionmode, respectively, which were subsequently vetted with
AMRT data (MycoMap), reducing the number of annotations to 624 and 366,
respectively (Figure S4).
MycoMap Database
The dataset exported as an Excel file was displayed as retention time versus
m/z on an Excel scatter plot to identify clusters. One lead compound in each
group was assigned a chemical formula when it passed all tests: matching
the mass of a known lipid family in MycoMass within 10 ppm, matching the
alkylform patterns in MycoMass, matching the RT of standards when avail-
able, and showing expected fragmentation patterns (Figure S4). Retention
times were matched for triglycerides (trioleyl, Avanti), phthiocerol dimycocer-
osate and mannosyl phosphomycoketide (synthetic, A. J. Minnaard) (Casas-
Arce et al., 2008; van Summeren et al., 2006), sulfoglycolipids (purified,
M. Gilleron), phosphatidylinositol and monoacyl PIM2 (in-house purified),
mycobactin and carboxymycobactin (from M. bovis BCG, C. Ratledge), and
glucose monomycolate and trehalose monomycolate (Moody et al., 2002;
Moody et al., 2000). Finally, fine mapping assigned a molecular formula, m/z
and retention time to each alkylform to create MycoMap.
Comparative Lipidomics
XCMS data matrices listing detected features, median m/z, and median RT
of triplicate lipidic extracts were imported into Mass Profiler Professional
(B.02.00) for pairwise comparison (two strains in triplicate) using the Student’s
paired t test with multiple testing correction (Benjamini and Hochberg,
1995). Features were identified by database matching or collisional mass
spectrometry.
Mouse Infection
After aerosol inoculation of C3H mice with M. tuberculosis Erdman 2.5
(200 organisms/mouse), mice were sacrificed after 8 weeks. Lung pairs
were homogenized in PBS with a bead-beater as previously described
(Kamath and Behar, 2005). Homogenates were washed twice with 5 ml of
PBS (2,000 rpm, 10 min). The pelleted material was extracted in 3 ml of meth-
anol, vortexed, and transferred to 6 ml of chloroform and methanol and9, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1547
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Mycobacterial Lipidomicsextracted as above. M. tuberculosis Erdman culture used for mouse infection
was maintained in parallel in triplicate and extracted as described above.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.chembiol.2011.10.013.
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